Renal Failure Treatment Market By Type (Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI)), By Treatment (Dialysis, {Hemodialysis, Peritoneal Dialysis}, Kidney Transplantation, {Living Donor Transplants, Deceased Donor Transplants}, Pharmacological Treatment, {Erythropoiesis-Stimulating Agents, Phosphate Binders, Immunosuppressive Drugs, Others), By End-user (Hospitals, Dialysis Centers, Home Care Settings, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Type

• Chronic Kidney Disease (CKD)
• Acute Kidney Injury (AKI)

By Treatment

• Dialysis
  • Hemodialysis
  • Peritoneal Dialysis
• Kidney Transplantation
  • Living Donor Transplants
  • Deceased Donor Transplants
• Pharmacological Treatment
  • Erythropoiesis-Stimulating Agents
  • Phosphate Binders
  • Immunosuppressive Drugs
  • Others

By End-user

• Hospitals
• Dialysis Centers
• Home Care Settings
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Fresenius Medical Care AG & Co. KGaA
• DaVita Inc.
• B. Braun Melsungen AG
• Nipro Corporation
• Terumo Corporation
• Medtronic PLC
• Asahi Kasei Medical Co., Ltd.
• Kaiser Permanente
• Baxter International Inc.
• Rockwell Medical, Inc.
• Dialysis Clinic, Inc. (DCI)
• St. Jude Medical (Abbott Laboratories)
• Humares
• Quanta Dialysis Technologies
• Southmedic Inc.